Status:

COMPLETED

GABA-glutamate Interactions and Psychosis

Lead Sponsor:

Yale University

Collaborating Sponsors:

National Alliance for Research on Schizophrenia and Depression

Conditions:

Cognitive Dysfunction

Eligibility:

All Genders

21-45 years

Phase:

PHASE1

Brief Summary

This study investigates the interactions between NMDA (N-Methyl-D-aspartic acid) antagonism and GABA (gamma-aminobutyric acid) system as it relates to cognitive function assessed by ERPs (event-relate...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Ages of 21-45 years from all ethnic backgrounds.
  • Male or female.
  • Written informed consent.
  • Exclusion criteria:
  • DSM-IV diagnosis for a psychotic, depressive or anxiety disorder.
  • A history of significant medical/neurological disease such as cardiac, thyroid, renal, hepatic abnormality, seizure disorder. Unstable medical condition based on EKG, vital signs, physical examination and laboratory work-up (CBC with differential, SMA-7, LFTs, TFTs, UA, Utox).
  • History of abnormal EEG.
  • History of severe allergies or multiple adverse drug reactions.
  • Any medication that could interfere with either the safety of the study and/or the outcome measures.
  • Any other conditions which in the opinion of the investigator would preclude participation in the study.
  • History of major psychiatric disorder in first degree relatives.
  • Current substance abuse/dependency determined by urine toxicology.
  • Treatment with medications with CNS effects.
  • Treatment with benzodiazepines within one week prior to testing.
  • Current treatment with medications with psychotropic effects.
  • Education \< 10th grade.
  • IQ \< 70, MR.
  • Non-English speaking.

Exclusion

    Key Trial Info

    Start Date :

    January 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 2 2018

    Estimated Enrollment :

    23 Patients enrolled

    Trial Details

    Trial ID

    NCT00611572

    Start Date

    January 1 2007

    End Date

    October 2 2018

    Last Update

    July 22 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    VHA Connecticut

    West Haven, Connecticut, United States, 06516